CoChat
Sign Up
Cited by 23

The DOI matches its Crossref record.

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes

Miyagawa, Yoshitaka, Verlengia, Gianluca, Reinhart, Bonnie, Han, Fang, Uchida, Hiroaki, Zucchini, Silvia, Goins, William F., Simonato, Michele, Cohen, Justus B., Glorioso, Joseph C.·2017·Molecular Therapy - Methods & Clinical Development
DOI 10.1016/j.omtm.2017.06.001PMC PMC5493822
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2017.06.001

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 46

  1. Puskovic, 2004, Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo, Mol. Ther., 10, 67, 10.1016/j.ymthe.2004.04.004 · DOI
  2. Smith, 2000, Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system, J. Gen. Virol., 81, 649, 10.1099/0022-1317-81-3-649 · DOI
  3. Zhu, 2000, Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector, Mol. Ther., 2, 82, 10.1006/mthe.2000.0093 · DOI
  4. Palmer, 2000, Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system, J. Virol., 74, 5604, 10.1128/JVI.74.12.5604-5618.2000 · DOI
  5. Perez, 2004, Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo, Gene Ther., 11, 1023, 10.1038/sj.gt.3302258 · DOI
  6. Goss, 2011, HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation, Mol. Ther., 19, 500, 10.1038/mt.2010.246 · DOI
  7. Goss, 2001, Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion, Gene Ther., 8, 551, 10.1038/sj.gt.3301430 · DOI
  8. McMenamin, 1998, A gamma34.5 mutant of herpes simplex 1 causes severe inflammation in the brain, Neuroscience, 83, 1225, 10.1016/S0306-4522(97)00513-7 · DOI
  9. Scarpini, 2001, Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors, Gene Ther., 8, 1057, 10.1038/sj.gt.3301497 · DOI
  10. Bloom, 1995, Long-term expression of a reporter gene from latent herpes simplex virus in the rat hippocampus, Brain Res. Mol. Brain Res., 31, 48, 10.1016/0169-328X(95)00031-M · DOI
  11. Boutell, 2013, Regulation of alphaherpesvirus infections by the ICP0 family of proteins, J. Gen. Virol., 94, 465, 10.1099/vir.0.048900-0 · DOI
  12. Chen, 2000, Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture, J. Virol., 74, 10132, 10.1128/JVI.74.21.10132-10141.2000 · DOI
  13. Goins, 1999, Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity, J. Virol., 73, 519, 10.1128/JVI.73.1.519-532.1999 · DOI
  14. Chattopadhyay, 2005, Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system, Mol. Ther., 12, 307, 10.1016/j.ymthe.2005.04.009 · DOI
  15. Margolis, 1993, Decreased reporter gene expression during latent infection with HSV LAT promoter constructs, Virology, 197, 585, 10.1006/viro.1993.1632 · DOI
  16. Labetoulle, 2003, HSV1 latency sites after inoculation in the lip: Assessment of their localization and connections to the eye, Invest. Ophthalmol. Vis. Sci., 44, 217, 10.1167/iovs.02-0464 · DOI
  17. Amelio, 2006, A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities, J. Virol., 80, 2358, 10.1128/JVI.80.5.2358-2368.2006 · DOI
  18. Miyagawa, 2015, Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity, Proc. Natl. Acad. Sci. USA, 112, E1632, 10.1073/pnas.1423556112 · DOI
  19. Rivas, 2016, Shutoff of host gene expression in influenza A virus and herpesviruses: Similar mechanisms and common themes, Viruses, 8, 102, 10.3390/v8040102 · DOI
  20. Smiley, 2004, Herpes simplex virus virion host shutoff protein: Immune evasion mediated by a viral RNase?, J. Virol., 78, 1063, 10.1128/JVI.78.3.1063-1068.2004 · DOI
  21. Strand, 2004, The virion host shutoff protein of herpes simplex virus type 1 has RNA degradation activity in primary neurons, J. Virol., 78, 8400, 10.1128/JVI.78.15.8400-8403.2004 · DOI
  22. Ferenczy, 2009, Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes, J. Virol., 83, 8514, 10.1128/JVI.00785-09 · DOI
  23. Hobbs, 2001, Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival, J. Virol., 75, 3391, 10.1128/JVI.75.7.3391-3403.2001 · DOI
  24. Glorioso, 2009, Herpes vector-mediated gene transfer in the treatment of chronic pain, Mol. Ther., 17, 13, 10.1038/mt.2008.213 · DOI
  25. Samaniego, 1998, Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins, J. Virol., 72, 3307, 10.1128/JVI.72.4.3307-3320.1998 · DOI
  26. Dauber, 2011, The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner, J. Virol., 85, 5363, 10.1128/JVI.00115-11 · DOI
  27. Pasieka, 2008, Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state, J. Virol., 82, 5527, 10.1128/JVI.02047-07 · DOI
  28. Strelow, 1995, Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis, J. Virol., 69, 6779, 10.1128/JVI.69.11.6779-6786.1995 · DOI
  29. Sciortino, 2013, The virion host shutoff RNase plays a key role in blocking the activation of protein kinase R in cells infected with herpes simplex virus 1, J. Virol., 87, 3271, 10.1128/JVI.03049-12 · DOI
  30. Suzutani, 2000, The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection, J. Gen. Virol., 81, 1763, 10.1099/0022-1317-81-7-1763 · DOI
  31. Mossman, 2000, Herpes simplex virus ICP0 mutants are hypersensitive to interferon, J. Virol., 74, 2052, 10.1128/JVI.74.4.2052-2056.2000 · DOI
  32. Nichol, 1994, Infection of sympathetic and sensory neurones with herpes simplex virus does not elicit a shut-off of cellular protein synthesis: Implications for viral latency and herpes vectors, Neurobiol. Dis., 1, 83, 10.1006/nbdi.1994.0011 · DOI
  33. Lin, 2004, The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes, J. Virol., 78, 1675, 10.1128/JVI.78.4.1675-1684.2004 · DOI
  34. Orzalli, 2016, Relative contributions of herpes simplex virus 1 ICP0 and vhs to loss of cellular IFI16 vary in different human cell types, J. Virol., 90, 8351, 10.1128/JVI.00939-16 · DOI
  35. Goins, 2011, Generation of replication-competent and -defective HSV vectors, Cold Spring Harb. Protoc., 10.1101/pdb.prot5615 · DOI
  36. Li, 2010, Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells, J. Neurosci. Methods, 189, 56, 10.1016/j.jneumeth.2010.03.019 · DOI
  37. Wilhelm, 2011, The human ubiquitin C promoter drives selective expression in principal neurons in the brain of a transgenic mouse line, Neurochem. Int., 59, 976, 10.1016/j.neuint.2011.07.008 · DOI
  38. Harkness, 2014, Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells, J. Virol., 88, 6847, 10.1128/JVI.00516-14 · DOI
  39. Knipe, 2015, Nuclear sensing of viral DNA, epigenetic regulation of herpes simplex virus infection, and innate immunity, Virology, 479-480, 153, 10.1016/j.virol.2015.02.009 · DOI
  40. Krisky, 1998, Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons, Gene Ther., 5, 1593, 10.1038/sj.gt.3300766 · DOI
  41. Tischer, 2010, En passant mutagenesis: A two step markerless red recombination system, Methods Mol. Biol., 634, 421, 10.1007/978-1-60761-652-8_30 · DOI
  42. Gierasch, 2006, Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS, J. Virol. Methods, 135, 197, 10.1016/j.jviromet.2006.03.014 · DOI
  43. Uchida, 2013, Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus, Mol. Ther., 21, 561, 10.1038/mt.2012.211 · DOI
  44. Uchida, 2010, A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection, J. Virol., 84, 12200, 10.1128/JVI.01633-10 · DOI
  45. Berthomme, 2001, Enhancer and long-term expression functions of herpes simplex virus type 1 latency-associated promoter are both located in the same region, J. Virol., 75, 4386, 10.1128/JVI.75.9.4386-4393.2001 · DOI
  46. Goins, 1994, A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats, J. Virol., 68, 2239, 10.1128/JVI.68.4.2239-2252.1994 · DOI

Cited by

Sorted by citations

Metadata

Authors
Miyagawa, Y., Verlengia, G., Reinhart, B., Han, F., Uchida, H., Zucchini, S., Goins, W. F., Simonato, M., Cohen, J. B., & Glorioso, J. C.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2017-09
Volume
6
Pages
79-90
ISSN
2329-0501
DOI
10.1016/j.omtm.2017.06.001
PMC
PMC5493822
Cited by
23
References
0
Language
en
Licence
Funders
  • NIH (NS064988, DK044935)
  • CHDI Foundation (A3777, A8790)
  • Commonwealth of Pennsylvania (SAP #4100061184)
  • European Community (FP7-PEOPLE-2011-IAPP project 285827 [EPIXCHANGE])
  • Italian Ministry for Education, University and Research (PRIN project 2010N8PBAA [INBDNF])

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review